Skip to content

The effect assessment of nebulized andrographolide sulfonate on the treatment of acute respiratory distress syndrome in children: A single center,prospective, pre exploratory clinical study

The effect assessment of nebulized andrographolide sulfonate on the treatment of acute respiratory distress syndrome in children: A single center,prospective, pre exploratory clinical study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17012450
Enrollment
Unknown
Registered
2017-08-23
Start date
2017-09-21
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome in children

Interventions

Experience group:Nebulization inhalation Andrographolide sulfonate
Control:inhalation 0.9%NS

Sponsors

Beijing Children's Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. children was admitted to PICU in Beijing Children's Hospital During the study; 2. children meet the P-ARDS criteria for moderate to severe diagnosis and require endotracheal intubation and ventilator assisted ventilation treatment; 3. Aged 29 days to 18 years old children.

Exclusion criteria

Exclusion criteria: (1) children was correcting the gestational age for less than 41 weeks; (2) children was chronic lung disease requiring long-term oxygen therapy; (3) the presence of other diseases have great influence on the removal of endotracheal intubation, tracheal stenosis and severe tracheomalacia tracheal diseases, serious heart disease, severe brain injury (Glasgow score < 8), neuromuscular disease; (4) long-term use of glucocorticoids because of the underlying diseases, basic diseases has a great impact on ARDS in children.

Design outcomes

Primary

MeasureTime frame
case fatality rate;

Secondary

MeasureTime frame
Inflammatory index;duration of mechanical ventilation;Oxygenation index;

Countries

China

Contacts

Public ContactSUYUN QIAN

Beijing Children's Hospital affiliated to Capital Medical University

syqian1211@163.com+86 13370115029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026